UNSPSC 51191515: Hydrochlorothiazide

This classification denotes a thiazide diuretic with the molecular formula C7H8ClN3O4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0J48LPH2TH, chemically known as 6-chloro-7-sulfamoyl-2h-1,2,4-benzothiadiazine 1,1-dioxide but generally known as hydrochlorothiazide, which bears US NIH Compound Identifier 2720. European Medicines Agency schedules Hydrochlorothiazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08062MIG.

UNSPSC 51191515 Hydrochlorothiazide is a Commodity code nominally designating a specific antihypertensive pharmaceutical, yet recent state and local activity under this code shows a mismatch with the code's nominal scope. The City of Meriden's July 2026 solicitation B027-15 (IFB) seeks sodium bisulfite, a chemical water-treatment agent unrelated to hydrochlorothiazide. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802, posted January 2026 with responses due March 26, 2026, targets generic multi-source pharmaceuticals and OTC products across state and local government facilities in Minnesota and Oregon, but does not identify hydrochlorothiazide as a named product or therapeutic category within its procurement scope. The code shows little relevant recent activity aligned to its nominal pharmaceutical designation.

State and local procurement under this code does not reflect consistent sourcing of hydrochlorothiazide itself. The Meriden water-treatment solicitation and the MMCAP pharmaceutical RFP, both posted within six months, appear to be routine misfiling or categorical drift rather than indicators of active hydrochlorothiazide procurement by state and local health agencies, pharmacy benefit programs, or correctional and institutional facilities that would typically stock the drug. Geographic spread is limited to Connecticut and Minnesota-Oregon cooperative purchasing based on the recent record. Pursuit of opportunities tagged to this code should be contingent on verification that the actual requirement aligns with hydrochlorothiazide supply or related pharmaceutical sourcing before bid preparation.